pharma Β· Infertility Β· Ovarian Cancer Β· NWBO
NORTHWEST BIOTHERAPEUTICS
NORTHWEST BIOTHERAPEUTICS INC
NORTHWEST BIOTHERAPEUTICS trial registry β 35 ClinicalTrials.gov studies with program phase, status, and indication context.
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO Β· NYSE Ticker
Company details
- Status
- Public
- HQ
- 4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
- Founded
- 1998
- Employees
- 20
- Programs
- 33
- Drugs
- 40
- Patents
- 595
NORTHWEST BIOTHERAPEUTICS clinical trials
Registry index of 35 ClinicalTrials.gov studies linked to NORTHWEST BIOTHERAPEUTICS programs β each row shows trial ID, program name, phase, status, and indication.
NORTHWEST BIOTHERAPEUTICS trial registry β 35 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for NORTHWEST BIOTHERAPEUTICS.
-
PRODIGE 107-ENGIC01-COLOSOTO β Phase 2
Clinical update -
Specific Carbohydrate Diet β Unknown
Clinical update -
Mifepristone β Approved
Clinical update -
Leuprolide or goserelin β Phase 2
Clinical update -
Ketamine Hydrochloride β Approved
Clinical update -
Generic cetrorelix acetate β Unknown
Clinical update -
ERA β Unknown
Clinical update -
Omega-3 fatty acids β Phase 1
Clinical update
Trial registry
-
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β - NCT03014804CT.gov β
autologous dendritic cells pulsed with tumor lysate antigen Vaccine
Giant Cell Glioblastoma
-
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β